title: [Indications for urgent coronary angiography. Part II: Acute coronary syndromes without ST-segment elevation].
abstract: The optimal treatment strategy for patients presenting with an acute coronary syndrome without ST elevation is controversial and different therapeutic approaches are recognized. Currently, given the literature available, it is not possible to recommend a universal systematic invasive approach. It is essential to individually risk stratify patients in order to identify those high risk patients that have been shown to benefit from an invasive strategy. Compared to conservative medical treatment, patients at low risk have not been shown to benefit from an invasive strategy. Urgent coronary angiography remains recommended for those patients with persistent or recurrent ischemic symptoms under optimal medical treatment.
authors.affiliation: Service de cardiologie, CHUV, 1011 Lausanne. juan-fernando.iglesias@chuv.ch
authors.forename: J F
authors.initials: JF
authors.lastname: Iglesias
authors.forename: C
authors.initials: C
authors.lastname: Roguelov
authors.forename: T
authors.initials: T
authors.lastname: Kabir
authors.forename: P
authors.initials: P
authors.lastname: Vogt
authors.forename: E
authors.initials: E
authors.lastname: Eeckhout
mesh_terms: D054058:Acute Coronary Syndrome / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000503:physiopathology / Q000628:therapy*; D000465:Algorithms; D015906:Angioplasty, Balloon, Coronary; D015415:Biomarkers / Q000097:blood; D017023:Coronary Angiography; D004562:Electrocardiography; D004638:Emergency Treatment; D006801:Humans; D015201:Meta-Analysis as Topic; D017410:Practice Guidelines as Topic; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D014336:Troponin / Q000097:blood
chemical_list: D015415:Biomarkers; D014336:Troponin